The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
Lawyers involved in mass tort litigation should be aware of this January 24, 2019 article (some would say puff piece) in Science regarding Dr. David Egilman, as well as some of quotes in it. The title is: “Expert witness David Egilman wins billions—and makes enemies—as he fights companies over public health.” The author, Douglas Starr, is co-director of the Boston University Science Journalism Program.
Issues arising from criminal prosecutions of former managers at an asbestos-cement plant (Everite) are up on appeal, as described in a February 2, 2021 post at the Ban Asbestos Secretariat run by Ms.
As if to highlight my point about strategic lawsuits taking on more importance, this week ended with another voting machine company filing a defamation suit against numerous defendants who were part o
As noted on Monday, it seems there are more and more strategic defamation suits against media in the US. Perhaps the trend includes the UK? One can wonder based on this new article regarding Prince Ha